GLP-1 SM 20mg Peptides

Precision begins where discipline meets purity, and every detail is accounted for.

Better Molecule GLP-1 SM is a research-grade lyophilized peptide supplied in a sealed laboratory vial for controlled handling. This unflavored, sterile format supports careful method development and consistent results across experiments, with a total content of 20mg per vial to streamline planning and inventory management.

  • Each vial contains 20mg of GLP-1 SM, provided as a lyophilized peptide intended for solution preparation, assay standardization, and reproducible in vitro applications.

Engineered for laboratory use, this material is designed to reconstitute cleanly in an appropriate sterile diluent, forming a clear solution when handled under standard aseptic technique. Its presentation supports protocol optimization, receptor-binding investigations, analytical calibration, and stability or compatibility assessments where consistency and traceability are essential. The lyophilized format aids in storage longevity and transport reliability, helping maintain integrity from receipt through final data collection.

Each lot is produced with rigorous controls to promote identity, potency, and purity. Batches are verified using HPLC and mass spectrometry to confirm composition and assess related impurities, with supporting documentation available to aid quality review. Vials are sealed and lot-coded for chain-of-custody assurance, and packaging is selected to protect against moisture and light during routine laboratory handling. As a USA-based supplier, Better Molecule maintains disciplined standards for sourcing, documentation, and fulfillment to support professional research environments.

For best results, handle using appropriate laboratory precautions. Store under suitable cold, dry conditions and avoid unnecessary freeze-thaw cycles after reconstitution. Consult the included lot documentation for storage guidance and testing details relevant to your protocol validation and recordkeeping.

Trust Better Molecule: We prioritize purity, consistency, and transparency. Our peptides are produced under controlled conditions, verified by analytical testing, and supported by lot-level documentation to meet the expectations of modern research labs.

For laboratory research use only. Not for human or animal consumption, medical use, diagnostic use, or household use. All handling should follow institutional and regulatory laboratory standards.

Total Strength
20mg
Strength Per vial
20mg/vial
Total Units
1 vial
Weight
0.70oz
Total GLP-1 SM Compounds
20mg
GLP-1 SM Compounds Per vial
20mg/vial

View
GLP-1 SM 20mg Peptides
View
GLP-1 SM 20mg Peptides

  • Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
  • Shipping is free on orders of $99+ (except Hawaii and Alaska).
  • All orders ship in discreet packaging via USPS Ground Advantage mail.

Delivery restrictions vary by state.

Related Products

Customer Reviews

5.0
  • 1
  • 2
  • 3
  • 4
  • 5
Based on 1 review
Reviews (1)
My order qualified for free standard shipping, which was a nice surprise at checkout. It arrived in three business days, and the vial was sealed and packed securely.

GLP-1 SM 20mg Peptides

Frequently Asked Questions

What is GLP-1 SM?

GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.

What is GLP-1 SM typically studied for?

GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.

What are GLP peptides?

GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.

A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Better Molecule are lyophilized research materials intended solely for in vitro laboratory investigation.

How do GLP analogs differ from native GLP hormones?

Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.

This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.

What is the difference between GLP-1, GLP-2, and GLP-3 in research?

GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.

GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.

Recently Viewed